Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disturbance; Vision, Loss”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Large-scale testing (Phase 3)Study completedNCT04503551
What this trial is testing

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm

Who this might be right for
Diabetic Retinopathy
Hoffmann-La Roche 174
Large-scale testing (Phase 3)Study completedNCT01003639
What this trial is testing

Idiopathic Intracranial Hypertension Treatment Trial

Who this might be right for
Idiopathic Intracranial Hypertension
St. Luke's-Roosevelt Hospital Center 165
Not applicableUnknownNCT04878861
What this trial is testing

Rehabilitating Visual Deficits Caused by Stroke

Who this might be right for
HemianopiaHemianopsiaQuadrantanopia+1 more
University of Oxford 20
Large-scale testing (Phase 3)Looking for participantsNCT07140783
What this trial is testing

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

Who this might be right for
Vision Loss NightVision Disorders
Ocuphire Pharma, Inc. 580
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537
What this trial is testing

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 168
Not applicableEnded earlyNCT00262509
What this trial is testing

Emergency Egress and Information System for Persons With Vision Loss

Who this might be right for
Blindness
US Department of Veterans Affairs 17
Not applicableLooking for participantsNCT07577219
What this trial is testing

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

Who this might be right for
Low VisionCentral Visual ImpairmentMacular Degeneration
New England College of Optometry 12
Not applicableActive Not RecruitingNCT05439759
What this trial is testing

Factors in Learning And Plasticity: Healthy Vision

Who this might be right for
Central Visual ImpairmentMacular Degeneration
University of Alabama at Birmingham 120
Not applicableEnded earlyNCT05799066
What this trial is testing

Measuring Relative Afferent Pupillary Defect

Who this might be right for
Relative Afferent Pupil Defect (RAPD)
The University of Texas Medical Branch, Galveston 71
Not applicableStudy completedNCT05772780
What this trial is testing

MP-3 Biofeedback Training and Central Vision Loss

Who this might be right for
Age-Related Macular Degeneration
Amore Filippo 24
Not applicableStudy completedNCT04458935
What this trial is testing

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

Who this might be right for
Retinal HemangioblastomaVon Hippel-Lindau Disease
National Eye Institute (NEI) 25
Not applicableStudy completedNCT01262209
What this trial is testing

Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients

Who this might be right for
Glaucoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 16
Not applicableStudy completedNCT05246904
What this trial is testing

Validating a Self-fitting Hearing Aid

Who this might be right for
Hearing and Vision Loss
University of Minnesota 41
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Not applicableNot Yet RecruitingNCT03166072
What this trial is testing

Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers

Who this might be right for
Low Vision, One Eye, Unspecified EyeLow Vision Blindness
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 150
Not applicableStudy completedNCT00333879
What this trial is testing

Virtual Reality Mobility Training System for Veterans With Vision Loss

Who this might be right for
Blindness
US Department of Veterans Affairs 4
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Not applicableStudy completedNCT01653184
What this trial is testing

Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Wills Eye 30
Large-scale testing (Phase 3)Study completedNCT00001864
What this trial is testing

Amblyopia (Lazy Eye) Treatment Study

Who this might be right for
AmblyopiaAnisometropiaStrabismus
National Eye Institute (NEI) 20
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Next Page